FDA Inspection 1155063 - Regeneron Pharmaceuticals Inc - October 25, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Regeneron Pharmaceuticals Inc

Record Details

This FDA Inspection record concerns Regeneron Pharmaceuticals Inc, with an inspection on October 25, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Regeneron Pharmaceuticals Inc
Inspection Date: October 25, 2021
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · f2f814f1-cd34-4b8c-9b74-fb3e6156fa2d

Violation Codes4

21 CFR 211.113(b)21 CFR 211.19221 CFR 211.42(c)(10)(v)21 CFR 600.14(c)

Full citation text and observation details available on the Dashboard.